Migraine

• CLINICAL_TRIALS trial_result · 2026-04-15
  Clinical Trial Update: A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments [Phase 2]

  A Phase 2 dose-finding trial of Lu-AG09222 in adults with migraine who have not responded to prior preventive treatments is ongoing but curr…

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine [Phase 3]

  A Phase 3 clinical trial evaluating eptinezumab for chronic or episodic migraine in children and adolescents aged 6 to 17 is currently recru…

• CLINICAL_TRIALS research · 2026-04-14
  Clinical Trial Update: Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine [Phase 3]

  This clinical trial update describes a Phase 3 study evaluating the safety and efficacy of oral atogepant tablets in adults with migraine; r…

• CLINICAL_TRIALS research · 2026-04-14
  Clinical Trial Update: A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years [Phase 3]

  This Phase 3 clinical trial update describes a study of oral atogepant in adolescents aged 12 to 17 with chronic migraine to assess adverse …

• CLINICAL_TRIALS research · 2026-04-14
  Clinical Trial Update: A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM [NA]

  This clinical trial update describes a pivotal study evaluating the safety and efficacy of the Shiratronics Migraine Therapy System for migr…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2026-04-14
  Clinical Trial Update: Family Study of Affective and Anxiety Spectrum Disorders

  This is a completed clinical trial update for a family study of affective and anxiety spectrum disorders sponsored by the National Institute…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine [Phase 3]

  Pfizer is conducting a Phase 3 trial to evaluate Rimegepant (Nurtec ODT) in adolescents with frequent migraines. The study is currently recr…

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Nurse Intervention Trial [NA]

  A nurse intervention clinical trial evaluating outcomes for migraine and related headache disorders has been terminated.

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: New Methods for Evaluating Preventive Migraine Treatment [NA]

  A clinical trial update describing new methods for evaluating preventive migraine treatments, focusing on study design and assessment approa…

• CLINICAL_TRIALS research · 2026-04-09
  Clinical Trial Update: Migraine and Endometriosis: The FEMININE Study

  The FEMININE clinical study, sponsored by Hospital Universitari Vall d'Hebron Research Institute, targets migraine and endometriosis and is …

• CLINICAL_TRIALS research · 2026-04-08
  Clinical Trial Update: A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine [Phase 3]

  A Phase 3 clinical trial is evaluating the efficacy and safety of Xeomin injections for preventing chronic migraine, and recruitment is ongo…

• CLINICAL_TRIALS research · 2026-04-08
  Clinical Trial Update: Facilitators and Barriers to Eptinezumab Administration in Thailand

  A completed clinical trial update examining facilitators and barriers to administering eptinezumab for migraine in Thailand.

• FDA approval · 2026-04-08
  FDA Approved: VALPROIC ACID — Supplemental Application (Bionpharma Inc.)

  FDA approved a supplemental application for Valproic Acid from Bionpharma Inc., for a generic product under ANDA 073484. This action confirm…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Pericranial and General Sensitivity in Patients With Primary Headache

  This clinical trial update notes ongoing enrollment by invitation for a study investigating pericranial and general sensitivity in patients …

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Headache Education and Awareness vs. Daily Mindfulness Strategies - Understanding Pain [NA]

  University of Colorado, Denver is conducting a trial comparing headache education to daily mindfulness strategies for migraine, including ad…

• CLINICAL_TRIALS research · 2026-04-06
  Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults [Phase 3]

  A Phase 3 clinical trial update evaluating the effectiveness and safety of Dysport for preventing episodic migraine in adults. The study is …

• CLINICAL_TRIALS research · 2026-04-06
  Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults [Phase 3]

  Ipsen's Phase 3 trial is evaluating the effectiveness and safety of Dysport for preventing chronic migraine in adults; the study is currentl…

• CLINICAL_TRIALS research · 2026-04-06
  Clinical Trial Update: Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine [NA]

  A clinical trial comparing greater occipital nerve block with pulsed radiofrequency for managing chronic migraine; the study is not yet recr…

• CLINICAL_TRIALS trial_result · 2026-04-03
  Clinical Trial Update: An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants

  A completed observational study evaluated the effectiveness of ubrogepant and atogepant tablets for treating migraine in adults.

• CLINICAL_TRIALS research · 2026-04-03
  Clinical Trial Update: Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study [Phase 4]

  Phase 4 study evaluating the comparative effectiveness of migraine preventive medications under the APT Comparison Study. The trial is curre…

• CLINICAL_TRIALS research · 2026-04-03
  Clinical Trial Update: Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada

  This clinical trial update covers a Canada-based study assessing function and satisfaction after multiple migraine attacks with oral ubrogep…

• CLINICAL_TRIALS trial_result · 2026-04-03
  Clinical Trial Update: Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment [Phase 4]

  Phase 4 trial update describes treatment patterns among US veterans using Theranica's remote electrical neuromodulation device Nerivio for a…

• CLINICAL_TRIALS research · 2026-04-02
  Clinical Trial Update: EXErcise in MIGraine [NA]

  An active, non-recruiting clinical trial investigating exercise for migraine in adults.

• CLINICAL_TRIALS research · 2026-04-02
  Clinical Trial Update: Migraine Manager (R01) [Phase 2]

  Phase 2 clinical trial update for the Migraine Manager (R01) indicates the study is active but not recruiting. The trial targets migraine co…

• FDA approval · 2026-03-31
  FDA Approved: VALPROIC ACID — Supplemental Application (ANI Pharmaceuticals, Inc.)

  FDA approved a supplemental application for valproic acid submitted by ANI Pharmaceuticals, Inc. The approval covers changes to the product …